Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
7h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
8h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
10h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
17h agoBuffalo Potash Files Annual Information Form and New Technical Report
18h agoIonik Announces 30-Day Extension of Senior Debt Facility
Ani Pharmaceuticals, Inc. logo

Ani Pharmaceuticals, Inc.

About

82.72USD-0.05 -0.06%
Closed • Updated at 21:30 GMT+00:00
Market Cap$1.88B
P/E Ratio20.98
Volume562.4K
Beta1.29
RSI57.78
Gross Margin51.14%
Health TechnologyBiotechnology

Ani Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 8 2026
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
Apr 24 2026
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
Apr 20 2026
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
Apr 13 2026
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
Apr 8 2026
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

Community Chat

Ask AI

Try asking
6ix6ixAIEvents